Skip to content

Effect Evaluation of Independent Medical Evaluation (IME) in Norway

Effect Evaluation of Independent Medical Evaluation (IME) After Six Months Sick Leave: A Randomized Controlled Trial of Independent Medical Evaluation (IME) Versus Treatment as Usual in Norway

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02524392
Acronym
NIME
Enrollment
7642
Registered
2015-08-14
Start date
2015-09-30
Completion date
2018-03-31
Last updated
2018-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All International Classification of Primary Care 2 Diagnoses

Keywords

independent medical evaluation, sick leave, sickness absence, physician primary care, general practitioner, family physician

Brief summary

A randomized controlled trial comparing independent medical evaluation (IME) to treatment as usual (TAU). Participants will be individuals reaching six months uninterrupted sickness absence. Treatment as usual (TAU) is normal follow-up by a general practitioner (GP).

Detailed description

A randomized controlled trial in a Norwegian context, involving an effect evaluation, a cost-benefit evaluation and a qualitative evaluation. Independent medical evaluation (IME) will be compared to treatment as usual (TAU). Independent medical evaluation (IME) will comprise a consultation with an independent general practitioner (IME GP) who will assess whether the sick listed worker has been given eligible and available opportunities in return to work follow-up in Norway. The independent medical evaluation general practitioner (IME GP) will write a short report that is sent to the treating general practitioner as input from a colleague. The report can be used in the follow-up of the sick listed participant. The participants in the treatment as usual (TAU) group will not receive any other follow-up than normal follow-up by the treating general practitioner. The qualitative evaluation will be conducted to gain insight into the experiences of the general practitioners and the participants.

Interventions

OTHERIndependent medical evaluation

The independent medical evaluation (IME) will be performed by specialists in general medicine, temporarily hired by the county welfare service. The independent medical evaluation (IME) procedure is developed by the Research Unit for General Practice at Uni Research Health in Norway.

Sponsors

Norwegian Labour and Welfare Administration
CollaboratorOTHER
NORCE Norwegian Research Centre AS
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 66 Years
Healthy volunteers
No

Inclusion criteria

* Participants on sick leave with an International Classification of Primary Care-2 diagnosis will be recruited through the Norwegian Labour and Welfare Administration's (NAV) registries, when reaching 22 weeks of sick leave (full or graded).

Exclusion criteria

* People with International Classification of Disease-10 diagnoses, cancer or dementia. * People who are pregnant.

Design outcomes

Primary

MeasureTime frameDescription
Change in sick leaveMeasured at three and eight weeks after randomization.Data on sickness benefits from official registers will be used to measure the primary outcome.

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026